P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES

• M. Gertz,
• A. Cohen,
• R. Comenzo,
• E. Kastritis,
• H. Landau,
• E. Libby,
• M. Liedtke,
• V. Sanchorawala,
• S. Schönland,
• A. Wechalekar,
• Y. Ando,
• Y. Koh,
• J. Zonder,
• G. Palladini,
• C. Nie,
• C. Karp,
• Y. Jin,
• A. Conrad,
• G. Kinney,
• G. Merlini

Affiliations

M. Gertz

1 Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

A. Cohen

2 Abramson Cancer Center, The Hospital of the University of Pennsylvania, Philadelphia, PA, USA

R. Comenzo

3 Division of Hematology and Oncology, Tufts Medical Center, Boston, MA, USA

E. Kastritis

4 Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

H. Landau

5 Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

E. Libby

1 Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

M. Liedtke

8 Stanford Cancer Institute, Stanford, CA, USA

V. Sanchorawala

9 Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA

S. Schönland

10 Medical Department V, Amyloidosis Center, Universitätsklinikum Heidelberg, Heidelberg, Denmark

A. Wechalekar

11 National Amyloidosis Centre, Division of Medicine, University College of London, Royal Free Hospital, London, United Kingdom

Y. Ando

12 Department of Amyloidosis Research Nagasaki International University, Sasebo, Japan

Y. Koh

13 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

J. Zonder

14 Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA

G. Palladini

1 Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

C. Nie

17 Prothena Biosciences Inc, South San Francisco, CA, USA

C. Karp

17 Prothena Biosciences Inc, South San Francisco, CA, USA

Y. Jin

17 Prothena Biosciences Inc, South San Francisco, CA, USA

A. Conrad

17 Prothena Biosciences Inc, South San Francisco, CA, USA

G. Kinney

17 Prothena Biosciences Inc, South San Francisco, CA, USA

G. Merlini

1 Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA